Company Analysis
Sign in

Phibro Animal Health Corporation (PAHC)

Nasdaq: PAHC · Pharmaceutical Preparations · Teaneck, NJ · filing with the SEC since 1998
Full chart Alerts Compare
Grade6.4
◀ Past 8.0● Present 6.4▶ Future 4.7
OverviewBusinessFinancialsGradeForecastSentimentOwnershipPeopleFilingsPatents Chart
The companyfiscal 2026, as filed
Revenue$1.52B+17.1%
Net income$99.7M+106.6%
Earnings per share$2.43+104.2%
Operating cash flow$69.0M-13.9%
Cash$61.4M-9.7%
Debtn/a
Shareholders’ equity$385M+34.9%
Shares, diluted41.0M+0.7%
Return on equity25.9%
The recordfrom its filings
Filings in 202679
Newest filingNov 4 · 8-K
Annual reportAug 26, 2026
Quarterly reportNov 4, 2026
Next report due10-Q by Feb 9
Insider sales, 12 months$13.8M
Insider buys, 12 months$300,000
Patents granted58
Filer categoryLarge accelerated filer
Trailing twelve months to Sep 2026Revenue $1.54BNet income $103MCash from operations $85.7Mthe four newest filed quarters added
Left: the newest annual report, with the change on the year before. Right: counted from the company's own filings with the SEC.
Revenue and net income by fiscal yearRevenueNet income
17181920212223242526
As filed, in USD. Nothing here is a forecast.

News

Nov 4, 2026 · SEC EDGAR · Form 8-K
Results released
Open the filing on sec.gov
Nov 4, 2026 · SEC EDGAR · Form 10-Q
Quarterly report
Open the filing on sec.gov
Nov 3, 2026 · SEC EDGAR · Form 8-K
Current report
Open the filing on sec.gov
Sep 18, 2026 · SEC EDGAR · Form DEFA14A
Extra proxy material
Open the filing on sec.gov
Sep 18, 2026 · SEC EDGAR · Form DEF 14A
Proxy statement
Open the filing on sec.gov
An outside story is shown by its headline, its source and its link only. The SI reads the page when you ask it to break one down.
SI Assistanton PAHC · research, not advice